A citation-based method for searching scientific literature

Carolina Caniffi, Flavia M Cerniello, Gonzalo Bouchet, María L Sueiro, Analía Tomat, Daniel González Maglio, Jorge E Toblli, Cristina Arranz. Pflugers Arch 2019
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mortality in achondroplasia study: a 42-year follow-up.
Julia Wynn, Terri M King, Michael J Gambello, D Kim Waller, Jacqueline T Hecht. Am J Med Genet A 2007
70
50

Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004.
Jeffrey A Cutler, Paul D Sorlie, Michael Wolz, Thomas Thom, Larry E Fields, Edward J Roccella. Hypertension 2008
621
50

Updated national and international hypertension guidelines: a review of current recommendations.
Sverre Kjeldsen, Ross D Feldman, Liu Lisheng, Jean-Jacques Mourad, Chern-En Chiang, Weizhong Zhang, Zhaosu Wu, Wei Li, Bryan Williams. Drugs 2014
66
50

Achondroplasia.
William A Horton, Judith G Hall, Jacqueline T Hecht. Lancet 2007
280
50


Comparison of forearm and upper arm blood pressures.
A J Singer, S R Kahn, H C Thode, J E Hollander. Prehosp Emerg Care 1999
22
50

C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
Robert C Olney, Timothy C R Prickett, Eric A Espiner, William G Mackenzie, Angela L Duker, Colleen Ditro, Bernhard Zabel, Tomonobu Hasegawa, Hiroshi Kitoh, Arthur S Aylsworth,[...]. J Clin Endocrinol Metab 2015
21
50


Reactive rise in blood pressure upon cuff inflation: cuff inflation at the arm causes a greater rise in pressure than at the wrist in hypertensive patients.
Alexia Charmoy, Grégoire Würzner, Christiane Ruffieux, Christopher Hasler, François Cachat, Bernard Waeber, Michel Burnier. Blood Press Monit 2007
18
50


Impact of age, phenotype and cardio-renal function on plasma C-type and B-type natriuretic peptide forms in an adult population.
T C R Prickett, R C Olney, V A Cameron, M J Ellis, A M Richards, E A Espiner. Clin Endocrinol (Oxf) 2013
32
50

Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.
Tatiana Nwankwo, Sung Sug Yoon, Vicki Burt, Quiping Gu. NCHS Data Brief 2013
406
50

Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.
V L Burt, P Whelton, E J Roccella, C Brown, J A Cutler, M Higgins, M J Horan, D Labarthe. Hypertension 1995
50

Clinical comparison of automatic, noninvasive measurements of blood pressure in the forearm and upper arm.
Kathleen Schell, Elisabeth Bradley, Linda Bucher, Maureen Seckel, Denise Lyons, Sandra Wakai, Deborah Bartell, Elizabeth Carson, Melanie Chichester, Teresa Foraker,[...]. Am J Crit Care 2005
33
50

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Cynthia F Bartels, Hulya Bükülmez, Pius Padayatti, David K Rhee, Conny van Ravenswaaij-Arts, Richard M Pauli, Stefan Mundlos, David Chitayat, Ling-Yu Shih, Lihadh I Al-Gazali,[...]. Am J Hum Genet 2004
228
50


Factors explaining excess stroke prevalence in the US Stroke Belt.
Youlian Liao, Kurt J Greenlund, Janet B Croft, Nora L Keenan, Wayne H Giles. Stroke 2009
90
50

Body mass index (BMI): the case for condition-specific cut-offs for overweight and obesity in skeletal dysplasias.
Kerry J Schulze, Yewande Adekemi Alade, John McGready, Julie E Hoover-Fong. Am J Med Genet A 2013
9
50



2
50

A new synthetic FGF receptor antagonist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient mice.
Frédérique Dol-Gleizes, Nathalie Delesque-Touchard, Anne-Marie Marès, Anne-Laure Nestor, Paul Schaeffer, Françoise Bono. PLoS One 2013
8
50

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Aram V Chobanian, George L Bakris, Henry R Black, William C Cushman, Lee A Green, Joseph L Izzo, Daniel W Jones, Barry J Materson, Suzanne Oparil, Jackson T Wright,[...]. Hypertension 2003
50

The birth prevalence rates for the skeletal dysplasias.
I M Orioli, E E Castilla, J G Barbosa-Neto. J Med Genet 1986
217
50

Is cardiac hypertrophy in spontaneously hypertensive rats the cause or the consequence of oxidative stress?
María Cecilia Alvarez, Claudia Caldiz, Juliana C Fantinelli, Carolina D Garciarena, Gloria M Console, Gladys E Chiappe de Cingolani, Susana M Mosca. Hypertens Res 2008
44
50

TGF-beta signaling in vascular fibrosis.
Marta Ruiz-Ortega, Juan Rodríguez-Vita, Elsa Sanchez-Lopez, Gisselle Carvajal, Jesús Egido. Cardiovasc Res 2007
378
50

Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.
Emmanuel S Buys, Michael J Raher, Sarah L Blake, Tomas G Neilan, Amanda R Graveline, Jonathan J Passeri, Miguel Llano, Teresa M Perez-Sanz, Fumito Ichinose, Stefan Janssens,[...]. Am J Physiol Heart Circ Physiol 2007
62
50

NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses.
Fan Jiang, Guei-Sheung Liu, Gregory J Dusting, Elsa C Chan. Redox Biol 2014
153
50

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.
A J Stingo, A L Clavell, D M Heublein, C M Wei, M R Pittelkow, J C Burnett. Am J Physiol 1992
237
50

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Takeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, Takeshi Tokudome, Takeshi Horio, Kenji Mori, Kenji Kangawa. J Am Coll Cardiol 2005
129
50


Autocrine and paracrine actions of natriuretic peptides in the heart.
Savio P D'Souza, Martin Davis, Gary F Baxter. Pharmacol Ther 2004
159
50

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
Sarah Mangiafico, Lisa C Costello-Boerrigter, Ingrid A Andersen, Alessandro Cataliotti, John C Burnett. Eur Heart J 2013
159
50

Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion.
Masanori Ozaki, Seinosuke Kawashima, Tomoya Yamashita, Tetsuaki Hirase, Yoshitaka Ohashi, Nobutaka Inoue, Ken-ichi Hirata, Mitsuhiro Yokoyama. Circ J 2002
66
50

Macrophages dictate the progression and manifestation of hypertensive heart disease.
David Kain, Uri Amit, Chana Yagil, Natalie Landa, Nili Naftali-Shani, Natali Molotski, Vered Aviv, Micha S Feinberg, Orly Goitein, Tammar Kushnir,[...]. Int J Cardiol 2016
36
50

Sex differences in the beneficial cardiac effects of chronic treatment with atrial natriuretic Peptide in spontaneously hypertensive rats.
Mariana Romero, Carolina Caniffi, Gonzalo Bouchet, Rosana Elesgaray, Myriam Mac Laughlin, Analía Tomat, Cristina Arranz, Maria A Costa. PLoS One 2013
11
50

Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the L-type Ca2+ current.
Honglan Wang, Mark J Kohr, Debra G Wheeler, Mark T Ziolo. Am J Physiol Heart Circ Physiol 2008
66
50

CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis.
Hiroaki Obata, Bobby Yanagawa, Koichi Tanaka, Shunsuke Ohnishi, Masaharu Kataoka, Yoshinori Miyahara, Hatsue Ishibashi-Ueda, Makoto Kodama, Yoshifusa Aizawa, Kenji Kangawa,[...]. Biochem Biophys Res Commun 2007
27
50

Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.
C M Thaik, A Calderone, N Takahashi, W S Colucci. J Clin Invest 1995
232
50

Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways.
Takeshi Tokudome, Takeshi Horio, Takeshi Soeki, Kenji Mori, Ichiro Kishimoto, Shin-ichi Suga, Fumiki Yoshihara, Yuhei Kawano, Masakazu Kohno, Kenji Kangawa. Endocrinology 2004
70
50


Regulation of cardiac calcium by mechanotransduction: Role of mitochondria.
Joon-Chul Kim, Min-Jeong Son, Sun-Hee Woo. Arch Biochem Biophys 2018
7
50

Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
Karl T Weber, Yao Sun, Syamal K Bhattacharya, Robert A Ahokas, Ivan C Gerling. Nat Rev Cardiol 2013
366
50



Independent of left ventricular mass, circulating inflammatory markers rather than pressure load are associated with concentric left ventricular remodelling.
Gavin R Norton, Vernice R Peterson, Chanel Robinson, Glenda Norman, Carlos D Libhaber, Elena Libhaber, Monica Gomes, Pinhas Sareli, Angela J Woodiwiss. Int J Cardiol 2019
9
50

C-type natriuretic peptide co-ordinates cardiac structure and function.
Amie J Moyes, Sandy M Chu, Aisah A Aubdool, Matthew S Dukinfield, Kenneth B Margulies, Kenneth C Bedi, Kairbaan Hodivala-Dilke, Reshma S Baliga, Adrian J Hobbs. Eur Heart J 2020
24
50

C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression.
Ramona S Scotland, Marc Cohen, Paul Foster, Matthew Lovell, Anthony Mathur, Amrita Ahluwalia, Adrian J Hobbs. Proc Natl Acad Sci U S A 2005
69
50

Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
Takeshi Horio, Takeshi Tokudome, Toshiyuki Maki, Fumiki Yoshihara, Shin-Ichi Suga, Toshio Nishikimi, Masayasu Kojima, Yuhei Kawano, Kenji Kangawa. Endocrinology 2003
132
50

Inflammation of different tissues in spontaneously hypertensive rats.
Li Sun, Yue-Hong Gao, Deng-Ke Tian, Jian-Pu Zheng, Chun-Yun Zhu, Yan Ke, Ka Bian. Sheng Li Xue Bao 2006
36
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.